Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for osteoporosis in adults with thalassemia major
2014-000931-18Phase 2Completed
- Sponsor
- Ersi Voskaridou-Dimoula
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoporosis and beta thalassemia major comparing Denosumab + vitamin D + calcium with Placebo + vitamin D + calcium (2 arms). Primary endpoint: Percent change from baseline in lumbar spine bone mineral density at 12 months. Started Apr 2014; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosisbeta thalassemia major
Beyond the preview
Go deeper on 2014-000931-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000931-18.